Thursday, August 22, 2013

Canesten 3 Vaginal Cream | Clotrimazole

Canesten 3 Vaginal Cream | Clotrimazole

Canesten 3

Clotrimazole 0.4 g / 20 g

Company Name
Memphis/Bayer - Egypt

Therapeutic Group

GYNAECOLOG ANTIFUNGALS

Pharmaceutical form

Vaginal Cream

Package
Tubes each containing 20 g with 3 vaginal applicators.

Indications

Infectious leucorrhoea, vaginitis caused by fungi - mostly Candida. Super infections caused by Canesten-sensitive bacteria.

Warning & Precautions

Experimental and clinical investigations give no indication that Canesten 3 has any harmful effects on the mother and child when administered during pregnancy. Sanitation of the birth canal should be ensured particularty during the last 4 - 6 weeks of pregnancy. During pregnancy, treatment should be carried out with Canesten vaginal tablets, since these can be-inserted without using an applicator.

Product Type
Human

Dosage

A three-day treatment is generally sufficient for vaginitis caused by fungi. Unless otherwise prescribed by the doctor, 1 applicator (approx. 5 g) should be inserted daily into the vagina as deeply as possible preferably at night - for three consecutive days. This is best achieved when lying back with the legs slightly drawn up. A new disposable applicator should be used for each application. If necessary, a second three-day treatment may be carried out. It is recommended that the treatment be timed to avoid the menstrual period and be finished before the onset of menstruation. In case of concomitant vulvitis or Candida balanitis of the sexual partner and in order to prevent re-infection, both partners should also undergo local treatment with Canesten 3 cream. Canesten 3 vaginal cream is odourtess and can be washed off.

Adverse Reactions

Local tolerability of Canesten 3 vaginal cream is generally good.

Contra Indications

NA

Drug Interactions

NA
5 EgyDrug Index: Canesten 3 Vaginal Cream | Clotrimazole Canesten 3 Clotrimazole 0.4 g / 20 g Company Name Memphis/Bayer - Egypt Therapeutic Group GYNAECOLOG ANTIFUNGALS Pharmaceutica...

No comments:

Post a Comment